<bill session="106" type="h" number="3677" updated="2013-07-14T18:54:34-04:00">
  <state datetime="2000-02-16">REFERRED</state>
  <status>
    <introduced datetime="2000-02-16"/>
  </status>
  <introduced datetime="2000-02-16"/>
  <titles>
    <title as="introduced" type="short">Thomas Navarro FDA Patient Rights Act</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to restrict the authority of the Food and Drug Administration to issue clinical holds regarding investigational drugs or to deny patients expanded access to such drugs.</title>
  </titles>
  <sponsor id="400055"/>
  <cosponsors>
    <cosponsor id="400514" joined="2000-02-16"/>
    <cosponsor id="400018" joined="2000-02-16"/>
    <cosponsor id="400024" joined="2000-04-12"/>
    <cosponsor id="400057" joined="2000-07-26"/>
    <cosponsor id="400573" joined="2000-05-10"/>
    <cosponsor id="400574" joined="2000-06-12"/>
    <cosponsor id="400071" joined="2000-09-06"/>
    <cosponsor id="400575" joined="2000-04-12"/>
    <cosponsor id="400576" joined="2000-03-06"/>
    <cosponsor id="400100" joined="2000-03-06"/>
    <cosponsor id="400113" joined="2000-02-16"/>
    <cosponsor id="400116" joined="2000-06-27"/>
    <cosponsor id="400523" joined="2000-06-09"/>
    <cosponsor id="400140" joined="2000-09-11"/>
    <cosponsor id="400536" joined="2000-02-16"/>
    <cosponsor id="400164" joined="2000-10-17"/>
    <cosponsor id="400165" joined="2000-10-04"/>
    <cosponsor id="400173" joined="2000-04-12"/>
    <cosponsor id="400178" joined="2000-05-11"/>
    <cosponsor id="400506" joined="2000-02-16"/>
    <cosponsor id="400192" joined="2000-05-23"/>
    <cosponsor id="400209" joined="2000-02-16"/>
    <cosponsor id="400228" joined="2000-02-16"/>
    <cosponsor id="400235" joined="2000-10-23"/>
    <cosponsor id="400594" joined="2000-09-06"/>
    <cosponsor id="400244" joined="2000-06-27"/>
    <cosponsor id="400596" joined="2000-03-06"/>
    <cosponsor id="400264" joined="2000-02-16"/>
    <cosponsor id="400597" joined="2000-02-16"/>
    <cosponsor id="400267" joined="2000-06-27"/>
    <cosponsor id="400511" joined="2000-02-16"/>
    <cosponsor id="400598" joined="2000-04-12"/>
    <cosponsor id="400299" joined="2000-05-11"/>
    <cosponsor id="400308" joined="2000-07-27"/>
    <cosponsor id="400311" joined="2000-02-16"/>
    <cosponsor id="400331" joined="2000-04-12"/>
    <cosponsor id="400332" joined="2000-09-20"/>
    <cosponsor id="400333" joined="2000-03-06"/>
    <cosponsor id="400338" joined="2000-10-12"/>
    <cosponsor id="400353" joined="2000-02-16"/>
    <cosponsor id="400607" joined="2000-06-06"/>
    <cosponsor id="400608" joined="2000-02-16"/>
    <cosponsor id="400507" joined="2000-09-11"/>
    <cosponsor id="400504" joined="2000-02-16"/>
    <cosponsor id="400394" joined="2000-03-06"/>
    <cosponsor id="400413" joined="2000-09-06"/>
    <cosponsor id="400420" joined="2000-06-29"/>
    <cosponsor id="400435" joined="2000-06-06"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2000-02-16">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="2000-02-23">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
    <action datetime="2000-12-15">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E2230-2231"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Clinical trials"/>
    <term name="Drug approvals"/>
    <term name="Drugs"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Law"/>
    <term name="Patients' rights"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>2/16/2000--Introduced.
Thomas Navarro FDA Patient Rights Act - Amends the Public Health Service Act to prohibit the Secretary of Health and Human Services from placing a clinical hold on an investigation of a drug on the basis that the Secretary has determined that: (1) there is another drug (including another investigational drug) that is or may be a safe and effective therapy for the disease or condition involved; or (2) there is a comparable or satisfactory alternative therapy available for a patient who is receiving or will receive the drug as a clinical subject in the investigation, subject to exception.</summary>
</bill>
